Log In Sign Up Premium
#1 AI Stock to Buy
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Economy
    • Industries
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Insider Trading Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Transcripts
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Investor Letters
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up

Our #1 AI Stock Pick is on a steep discount - 29.99$ instead of 99.99$! Click here to access exclusive investment research and ad free browsing!

Our #1 AI Stock Pick is on a steep discount - 29.99$ instead of 99.99$! Click here to access exclusive research!

Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Sanofi SA (ADR) (SNY)’

30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets

The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.

Keep Reading →

March 22 - News

Market Movers Today: Snap Inc (SNAP), Wynn Resorts, Limited (WYNN), Perry Ellis International, Inc. (PERY), and More

What happened: Shares of Snap (NYSE:SNAP) have skyrocketed today, up by 40% as of 12 p.m. EST, after the company reported strong fourth-quarter earnings.

Keep Reading →

February 7 - Market Movers, News

Top 10 Generic Pharmaceutical Companies In 2017

The top 10 generic pharmaceutical companies in 2017 operate in the relatively recession-proof pharmaceuticals industry which is immune from the vagaries of economic cycles.

Keep Reading →

December 13 - Lists, News

15 Best Selling Most Profitable Drugs of All Time

Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...

Keep Reading →

November 24 - News

Top 10 Largest Pharmaceutical Companies By Revenue in 2017

The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...

Keep Reading →

November 23 - News

Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales

Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen.

Keep Reading →

February 9 - News, Stock Analysis

11 Largest Pharmaceutical Companies In The World

Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...

Keep Reading →

January 26 - Lists, News

Sanofi SA (ADR) (SNY) Hit With Cease And Desist Order On Dengue Vaccine Ads In The Philippines

The Philippines Food and Drug Administration has ordered Sanofi SA (ADR) (NYSE:SNY) to desist from advertising its dengue vaccine or face major consequences.

Keep Reading →

January 4 - News, Stock Analysis

Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes

A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations.

Keep Reading →

January 3 - News, Stock Analysis

Regulator Demands Divestiture In Asset Swap Deal Between Boehringer, Sanofi SA (ADR) (SNY)

Boehringer Ingelheim, a German pharmaceutical firm, are involved in plans to divest of five kinds of products for animal health.

Keep Reading →

December 30 - News, Stock Analysis

Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims

Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims.

Keep Reading →

December 28 - News, Stock Analysis

EMA Reviews Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY) Dupixent MAA

The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (...

Keep Reading →

December 9 - News, Stock Analysis

Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF)

Sanofi SA (ADR) (NYSE:SNY) could spark a fierce bidding war for Actelion Ltd (OTCMKTS:ALIOF).

Keep Reading →

December 6 - News, Stock Analysis

Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters

Manufacturing problems in France threaten to delay the release of Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s blockbuster drug, dupilumab, according...

Keep Reading →

November 30 - News, Stock Analysis

US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6

The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy...

Keep Reading →

November 23 - News, Stock Analysis

Sanofi SA (ADR) (SNY) Can Thank Its Vaccines

Sanofi SA (ADR) (NYSE:SNY) Pasteur seems to be making it big with its vaccines. In the third quarter the French drugmaker’s sales grew by 14% over last year.

Keep Reading →

November 3 - News, Stock Analysis

Hedge Fund Managers Discuss Shorting Viasat (VSAT), 2U (TWOU), Long Positions in Microsoft (MSFT), Others

Large hedge funds are required to disclose all of their long stakes in U.S.-traded securities once per quarter.

Keep Reading →

November 1 - Hedge Fund Investor Letters, Hedge Funds, News

Why Investors Are Watching Dean Foods, Regeneron Pharmaceuticals, Halliburton, and More

It's another quiet day on the Street as the main indexes are moderately in the green while the VIX is down 3% to trade below 15.

Keep Reading →

October 28 - Market Movers, News

Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t

Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with...

Keep Reading →

September 6 - News, Stock Analysis

FDA’s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi

We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)’s insulin combo candidate IGlarLixi.

Keep Reading →

August 22 - News, Stock Analysis

Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?

It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve it.

Keep Reading →

August 11 - News, Stock Analysis

The Most Popular French Stocks Among Hedge Funds

French president François Hollande was recently quoted as saying “ça va mieux” of his country's economy, which means that things are improving.

Keep Reading →

July 15 - Economy, Hedge Funds, News

As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs

In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.

Keep Reading →

June 27 - News, Stock Analysis

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million.

Keep Reading →

June 22 - News, Stock Analysis

Why Traders Are Buzzing About MGM, Apple, and Three Other Companies Today

Although crude futures are well in the green, the three indexes have opened in the red on Friday. The Dow and S&P 500 are off by 0.2% while the NASDAQ index has lost around 0...

Keep Reading →

June 17 - Market Movers, News

GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market

GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.

Keep Reading →

June 8 - News, Stock Analysis

Warren Buffett’s Best High-Yield Dividend Stocks – May 2016 Update

Warren Buffett’s Berkshire Hathaway outperformed the S&P 500 by 11.1% per year from 1965-2015, generating an overall gain of 1,598,284% compared to the market’s total return...

Keep Reading →

May 18 - Dividend Stocks, News, Stock Analysis

Why These Five Stocks Are Trending Today?

The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus 200,000 expected.

Keep Reading →

May 6 - Market Movers, News

Why These Five Stocks Are on the Move Today?

Markets are trading lower on Friday following the recent sell-off in several tech  stocks amid the earnings season.

Keep Reading →

April 29 - Market Movers, News

Why Investors Are Buzzing About These Stocks Today

It's M&A Thursday, as several major M&A deals have been announced today.

Keep Reading →

April 28 - Market Movers, News

Warren Buffett’s Best High-Yield Dividend Stocks

Warren Buffett’s Berkshire Hathaway outperformed the S&P 500 by 11.1% per year from 1965-2015, generating an overall gain of 1,598,284% compared to the market’s total return...

Keep Reading →

April 26 - Dividend Stocks, News, Stock Analysis

Here’s Why These 5 Stocks Are on the Move Today

With the NASDAQ index in the red and the S&P 500 and Dow Jones Indexes barely in the green, shares of Highpower International Inc (NASDAQ:HPJ), Chesapeake Energy Corporation (...

Keep Reading →

April 12 - Market Movers, News

Billionaire Ken Fisher’s Top Healthcare Stock Picks

At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast...

Keep Reading →

November 3 - Hedge Fund Analysis, Hedge Funds, News

Why Are Investors Selling Shares of These Four Companies?

On a day where the S&P 500 is up by 0.82% and the NASDAQ is up by over 1%, shares of Green Brick Partners Inc (NASDAQ:GRBK), MannKind Corporation (NASDAQ:MNKD), Team Health Holdings...

Keep Reading →

November 2 - Market Movers, News

This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move

Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both...

Keep Reading →

September 28 - Market Movers, News

Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company

Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working on a novel method of...

Keep Reading →

February 13 - Hedge Funds, News

Regeneron Pharmaceuticals Inc (REGN) Calls Game, Set and Match On Its Competitor: Jim Cramer

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has, once again, shown today why biopharmaceuticals companies are so popular with investors, especially those with a speculative...

Keep Reading →

October 17 - News

InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks

Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.

Keep Reading →

September 9 - Hedge Funds, News

For Sanofi SA (ADR) (SNY) Chronic Diseases Present the Future Focus

In an interview with CNBC, Chris Viehbacher, the CEO of Sanofi SA (ADR) (NYSE:SNY), discussed the steps that big pharma companies like Sanofi SA (ADR) (NYSE:SNY) are taking to...

Keep Reading →

July 9 - News

Stocks to Watch on Thursday

Lululemon Athletica Inc.

Keep Reading →

June 12 - Market Movers

This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)

In the financial world, there are many methods market participants can use to track the equity markets.

Keep Reading →

September 3 - News

Hedge Funds Are Buying Novartis AG (ADR) (NVS)

In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.

Keep Reading →

August 29 - News

Is Sanofi SA (ADR) (SNY) Going to Burn These Hedge Funds?

To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.

Keep Reading →

August 22 - News

Sanofi SA (ADR) (SNY), Merck & Co., Inc. (MRK): Healthier Days Loom as 3 Big Pharmas Move on Dengue Shots

Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.

Keep Reading →

August 12 - News

Billionaire Ken Fisher’s Healthcare Picks for Q3 Include Pfizer Inc. (PFE)

In mid July, Fisher Asset Management, the asset management firm run by billionaire and Forbes columnist Ken Fisher, filed its 13F for the second quarter of 2013 with the SEC, ...

Keep Reading →

July 16 - Hedge Funds

Hedge Funds Are Betting On Pfizer Inc. (PFE)

Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.

Keep Reading →

June 24 - News

Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)

If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.

Keep Reading →

June 3 - News

This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)

To most investors, hedge funds are seen as slow, outdated financial vehicles of the past.

Keep Reading →

May 24 - News

Biogen Idec Inc. (BIIB) Bounces Higher

If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.

Keep Reading →

April 25 - News

General Motors Company (GM), Sanofi SA (ADR) (SNY): Ex-Lehman Hedge Fund’s Favorite Equities

Managed by the former head of Global Trading Strategies for Lehman Brothers, Realm Partners was started in 2009 by Robert Millard with $650 million.

Keep Reading →

April 24 - Hedge Funds

« Older Entries
Hedge Fund Resource Center
  • How to Best Use Insider Monkey to Increase Your Returns
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
  • 6 Things You Didn't Know About Hedge Funds
Hot Topics

Apple (AAPL)

Latest Stock News - Company Profile

Warren Buffett

News & Analysis - Portfolio & Stock Picks

Biggest Insider Purchases & Sales

News & Analysis - Data Screener

Google (GOOG)

Latest Stock News - Company Profile

Microsoft (MSFT)

Latest Stock News - Company Profile

Lists

30 Unhappiest Countries in the World in 2025

30 Unhappiest Countries in the World in 2025

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

5 Countries with the Most Beautiful Women in the World

5 Countries with the Most Beautiful Women in the World

20 Countries with the Most Beautiful Women in the World

20 Countries with the Most Beautiful Women in the World

20 US Cities with the Highest Homeless Population Per Capita

20 US Cities with the Highest Homeless Population Per Capita

20 Countries with the Highest Homeless Population

20 Countries with the Highest Homeless Population

12 Countries with the Highest Bond Yields in the World

12 Countries with the Highest Bond Yields in the World

20 Countries with the Most Battle Tanks in the World

20 Countries with the Most Battle Tanks in the World

12 Best Nasdaq Stocks Under $20 to Buy Now

12 Best Nasdaq Stocks Under $20 to Buy Now

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Worst Performing Currencies of 2024

10 Worst Performing Currencies of 2024

15 States with the Best Weed in America

15 States with the Best Weed in America

16 Countries with the Largest Proven Oil Reserves in the World

16 Countries with the Largest Proven Oil Reserves in the World

16 Highest Quality Chocolate Brands in the US

16 Highest Quality Chocolate Brands in the US

20 Countries with the Strongest Armies in the World

20 Countries with the Strongest Armies in the World

Top 13 English Speaking Countries in Asia

Top 13 English Speaking Countries in Asia

20 States with Highest Female to Male Ratio in the US

20 States with Highest Female to Male Ratio in the US

40 Best Places to Visit in Europe Before You Die

40 Best Places to Visit in Europe Before You Die

20 States with the Lowest Life Expectancy in the US

20 States with the Lowest Life Expectancy in the US

25 Cities with the Highest Homeless Population in the World

25 Cities with the Highest Homeless Population in the World

20 Countries With The Best English Accent in The World

20 Countries With The Best English Accent in The World

30 Cities with the Highest Weed Consumption in the US

30 Cities with the Highest Weed Consumption in the US

25 Countries with the Highest Alcohol Consumption per Capita

25 Countries with the Highest Alcohol Consumption per Capita

10 Best Gold Stocks Under $30

10 Best Gold Stocks Under $30

10 Best Genomics Stocks To Buy Right Now

10 Best Genomics Stocks To Buy Right Now

20 Countries with the Best Economy in the World in 2024

20 Countries with the Best Economy in the World in 2024

30 Cheapest Countries in the World in 2024

30 Cheapest Countries in the World in 2024

15 Healthiest Countries in Europe

15 Healthiest Countries in Europe

15 Healthiest Countries In Africa

15 Healthiest Countries In Africa

25 Most Tropical Cities in the US

25 Most Tropical Cities in the US

15 Most Underrated States in the US

15 Most Underrated States in the US

13 Best Cheap Perfumes for Women That Smell Amazing

13 Best Cheap Perfumes for Women That Smell Amazing

Best Cheap Perfume for Women That Smells Amazing

Best Cheap Perfume for Women That Smells Amazing

20 Most Industrialized Countries in Asia

20 Most Industrialized Countries in Asia

The Most Successful Celebrity Beauty Company in the World

The Most Successful Celebrity Beauty Company in the World

15 Most Successful Celebrity Beauty Companies in the World

15 Most Successful Celebrity Beauty Companies in the World

20 Best Places For Sex Tourism in the World

20 Best Places For Sex Tourism in the World

Top 20 U.S. Cities with the Highest Murders in 2024

Top 20 U.S. Cities with the Highest Murders in 2024

26 Most Dangerous Prisons In The World

26 Most Dangerous Prisons In The World

30 Cities with The Highest Murders Per Capita in 2024 in the World

30 Cities with The Highest Murders Per Capita in 2024 in the World

Top 10 Affordable Cities to Live in the US in 2024

Top 10 Affordable Cities to Live in the US in 2024

20 Budget-Friendly Corporate Gifts for Employees

20 Budget-Friendly Corporate Gifts for Employees

30 US Cities With Highest Homicide Rates In 2024

30 US Cities With Highest Homicide Rates In 2024

20 Countries With Darkest Skin Color in the World

20 Countries With Darkest Skin Color in the World

25 Easiest Countries to Get Laid in 2024

25 Easiest Countries to Get Laid in 2024

25 European Cities with Most Single Women

25 European Cities with Most Single Women

15 Dangerous Jobs That Pay $75,000 or More

15 Dangerous Jobs That Pay $75,000 or More

20 Gayest Cities in Europe

20 Gayest Cities in Europe

30 Most Hated Cities in the US

30 Most Hated Cities in the US

20 African Countries with Highest Divorce Rate

20 African Countries with Highest Divorce Rate

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use FAQ CCPA - Do Not Sell My Information. ©2025 Koala Guide LLC.